Ironwood amends IPO

Ironwood Pharmaceuticals Inc. (Cambridge, Mass.) amended its IPO and hopes to sell 16.7 million shares at $14-$16 in an offering underwritten by JPMorgan; Morgan Stanley; Credit Suisse; BofA Merrill Lynch; and Wedbush PacGrow Life Sciences. A $15 price would raise $250 million and value the company at $1.4 billion. In November, Ironwood filed to raise up to $172.5 million. ...